FDA — authorised 20 June 2024
- Application: BLA761388
- Marketing authorisation holder: GENENTECH INC
- Local brand name: PIASKY
- Indication: INJECTABLE — INTRAVENOUS
- Status: approved
🇺🇸 PIASKY in United States
FDA authorised PIASKY on 20 June 2024
Marketing authorisations
FDA
- Status: approved
PIASKY in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is PIASKY approved in United States?
Yes. FDA authorised it on 20 June 2024; FDA has authorised it.
Who is the marketing authorisation holder for PIASKY in United States?
GENENTECH INC holds the US marketing authorisation.